Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
7.12
0.00 (0.00%)
Mar 18, 2026, 4:00 PM EDT - Market closed
Climb Bio Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$15.50
Upside
+117.70%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +138.76% | Mar 18, 2026 |
| Raymond James | Raymond James | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +251.12% | Mar 11, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $15 | Strong Buy | Maintains | $11 → $15 | +110.67% | Mar 10, 2026 |
| Wedbush | Wedbush | Buy Maintains $12 → $14 | Buy | Maintains | $12 → $14 | +96.63% | Mar 6, 2026 |
| Baird | Baird | Buy Maintains $9 → $12 | Buy | Maintains | $9 → $12 | +68.54% | Mar 6, 2026 |
| Wedbush | Wedbush | Buy Initiates $12 | Buy | Initiates | $12 | +68.54% | Mar 5, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $23 | Buy | Initiates | $23 | +223.03% | Feb 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | +54.49% | Dec 18, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 16, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +12.36% | Oct 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +26.40% | Oct 13, 2025 |
| BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +12.36% | Sep 30, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | -1.69% | Sep 22, 2025 |
| Baird | Baird | Buy Initiates $9 | Buy | Initiates | $9 | +26.40% | Aug 15, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $10 | Buy | Initiates | $10 | +40.45% | Jun 6, 2025 |